Searchable abstracts of presentations at key conferences in endocrinology

ea0081oc2.5 | Oral Communications 2: Adrenal and Cardiovascular Endocrinology 1 | ECE2022

Elevated serum free cortisol is a strong predictor of mortality in hospitalized patients with Covid-19 irrespective of dexamethasone treatment

Rozenfeld Karina , Izkhakov Elena , Moshiashvili Miguel , Oster Howard , Tordjman Karen , Shefer Gabi , Greenman Yona

Serum total cortisol has been linked to increased mortality in patients with Covid-19, but its reliability in critically ill patients is limited. We examined the association between serum free cortisol (SFC) levels and clinical outcomes in patients hospitalized with Covid-19 between 5/5/2020 and 1/3/2021 in our institution. Methods: SFC was measured in blood samples collected at patient’s admission, prior to any medical treatment. Patients’ fil...

ea0070aep741 | Pituitary and Neuroendocrinology | ECE2020

Cushing’s syndrome in the 21st century, not what it used to be: A single institution experience

Rosset Arza , Greenman Yona , Shefer Gabi , Osher Etty , Stern Naftali , Tordjman Karen

Background: True Cushing’s syndrome (CS) is an exceedingly rare condition, thus to avoid unnecessary and costly testing, a diagnostic investigation should only start based on solid clinical suspicion. The current obesity epidemic has become a hurdle in discriminating subjects at real risk for CS from those with the metabolic syndrome. Moreover, many CS patientsrecently diagnosed do not fit the typical clinical profile of ‘at risk subjects’.<p class="abste...

ea0090p182 | Reproductive and Developmental Endocrinology | ECE2023

Sublingual estradiol only, offers no apparent advantage over combined oral estradiol and cyproterone acetate, for Gender Affirming Hormone Therapy (GAHT) of treatment-naïve transwomen: Results of a prospective pilot study

Gindis Guy , Yaish Iris , Greenman Yona , Moshe Yaffa , Arbiv Mira , Buch Asaf , Sofer Yael , Shefer Gabi , Tordjman Karen

Background: The standard approach for Gender-Affirming Hormone Therapy (GAHT) of transgender women (TW) in Israel is oral estradiol (OE) combined with the potent anti-androgen cyproterone acetate (CA). Recently, many of our non-binary patients have requested sublingual estradiol (SLE) without CA, under the unproven belief it preserves erectile function, and does not induce depression. Preliminary data in a few subjects, who self-practiced this approach, suggested it also maint...